7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Molecular basis of the outer membrane permeability (TRANSLOCATION)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2017,
Overcoming the barriers that the cell envelope and efflux pumps provide to Gram-negative bacteria is a major bottleneck in the discovery and development of new antibiotics. To respond to this Call we are extending our current network on antibiotic translocation and propose an ambitious project ranging from identification of novel resistance mechanisms in clinical bacterial isolates to crystallizat ...
Voir le projet
28
Participants partenaires
TERMINÉ
Infection biology training network: shaping the future of infectious diseases treatments (INBIONET)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,
"The increasing number of bacteria resistant to all antibiotics and antimicrobials and the virtual lack of antiviral drugs make necessary to develop therapeutics based on new targets/approaches. European-wide-acting sectors must permanently improve their capabilities and capacities to cope with these challenges. Thus, the demand for experts trained to understand infectious diseases in their whole ...
Voir le projet
11
Participants partenaires
TERMINÉ
European Modular Education and Training Programme in Safety Sciences for Medicines (SAFESCIMET)
Date du début: 1 janv. 2010, Date de fin: 30 nov. 2016,
Background:In current drug safety education and training in Europe, an integrative and translational approach is lacking. This shortfall has been identified by EUFEPS. The IMI (‘Strategic Research Agenda’), the FDA and the EMEA have also characterised this fact as a crucial gap in the education and training of scientists evaluating the safety of drug candidates and new medicines. Scope and objecti ...
Voir le projet
34
Participants partenaires
TERMINÉ
More Medicines for Tuberculosis (MM4TB)
Date du début: 1 févr. 2011, Date de fin: 31 juil. 2016,
The More Medicines for Tuberculosis (MM4TB) consortium evolved from the highly successful FP6 project, New Medicines for TB (NM4TB), that delivered a candidate drug for clinical development two years ahead of schedule. Building on these firm foundations and exploiting its proprietary pharmacophores, MM4TB will continue to develop new drugs for TB treatment. An integrated approach will be impleme ...
Voir le projet
27
Participants partenaires
TERMINÉ
European programme in Pharmacovigilance and Pharmacoepidemiology (EU2P)
Date du début: 1 sept. 2009, Date de fin: 30 juin 2016,
The Eu2P training network in Pharmacovigilance and Pharmacoepidemiology will meet the needs of industry,regulatory authorities and academia at the European level. It will give access to a harmonised training programme that gathers complementary specialized and eminent European partners. The Eu2P consortium consists of course providers with aproven record including the University of Bordeaux (Eu2P ...
Voir le projet
24
Participants partenaires
TERMINÉ
Modern polymer-based catalysts and microflow conditions as key elements of innovations in fine chemical syntheses (POLYCAT)
Date du début: 1 oct. 2010, Date de fin: 31 mars 2014,
POLYCAT provides an integrated, coherent and holistic approach utilizing novel polymer based nanoparticulate catalysts in pharmaceutical, crop protection and vitamin syntheses in conjunction with the enabling functions of micro process technology and “green” solvents such as water or ethyl lactate. This provides a discipline bridging approach between fine chemistry, catalysis and engineering. This ...
Voir le projet
22
Participants partenaires
TERMINÉ
Novel Polysaccharide Modifying Enzymes to Optimise the Potential of Hydrocolloids for Food and Medical Applications (PolyModE)
Date du début: 1 mai 2009, Date de fin: 30 avr. 2013,
The PolyModE project convenes an international, interdisciplinary, and intersectorial consortium to identify, characterise, and optimise novel polysaccharide modifying enzymes, and to develop robust fermentation strategies for their large-scale production, to exploit the potential of biopolymers for food, pharmaceutical, cosmetic, and technical applications. We have selected the six complex carboh ...
Voir le projet